European Archives - Page 68 of 989 - European Medical Journal

Study Finds Age-Related Bias in NLP Tools for Chest X-ray Annotation

Research has revealed that four commercially available natural language processing (NLP) tools used for annotating chest x-ray reports show high overall accuracy but exhibit significant age-related biases, with models performing poorly in patients over 80 years old

Jennifer Schranz, Ipsen

Ipsen's Jennifer Schranz on rethinking rare disease for women

Jennifer Schranz, SVP and Global Head of Rare Diseases, Ipsen, joins the podcast to discuss the burden faced by women with rare diseases.

AI Improves Maternity Care Outcomes

Clinical Decision Support Systems (CDSS) have shown potential to improve outcomes in maternity care. This systematic review aimed to identify and evaluate CDSS used in maternity settings, assessing their effectiveness and synthesizing evidence on their impact.

Dengue Vaccine Shows Promising Long-Term T Cell Response in Children and Adolescents

TAK-003, a live-attenuated tetravalent dengue vaccine, has now become a promising candidate for prevention of dengue, as demonstrated in a Phase II clinical trial.

Study Reveals Selenium's Role in Combatting Triple Negative Breast Cancer Spread

A study suggests that selenium, a mineral found in Brazil nuts, may hold the key to preventing the spread of triple negative breast cancer.

EMJ Oncology 12.1 2024

In our latest issue of EMJ Oncology you can find exclusive interviews with experts in the field, insightful peer-reviewed articles, and an…

Unravelling HER2+ Breast Cancer

A highly engaging infographic providing information on the incidence, diagnosis and treatment options for HER2+ breast cancer. It touches…

The latest edition of EMJ Oncology

The latest edition of EMJ Oncology is out now, featuring coverage from the 2024 European Society for Medical Oncology Congress…

Review of the European Society for Medical Oncology (ESMO) Congress 2024

KNOWN for its research excellence in the fields of oncology, bionanomedicine, and cardiovascular disease, Barcelona, Spain, provided the…

ER+/HER2- Metastatic Breast Cancer – Treatment after ET + CDK4/6i

Over 70% of breast cancers are ER+/HER2-, for which the backbone of treatment is ET.1-3 Advanced breast cancer (aBC) can be considered to…